Delivery Order SPE2DB20D2014-SPE2DB25FC64U
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 100 tablets of Concerta ER 36 mg with a ceiling value of $1,857.96 under a firm fixed price contract type. The award, issued on August 22, 2025, represents a competitively awarded, non-set-aside procurement with an ultimate completion date of August 25, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order valued at $45,836.39 to AmerisourceBergen Drug Corp for the supply of Concerta ER 36 mg tablets (100 count) on August 11, 2025, with an ultimate completion date of August 12, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a $2,822.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Concerta ER 36 mg tablets (100 count) on July 31, 2025, with an ultimate completion date of August 1, 2025. This non-set-aside contract represents a small-value pharmaceutical procurement executed through AmerisourceBergen's existing indefinite delivery contract vehicle with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Concerta ER 36 mg tablets (100 count) with a ceiling value of $5,428.87. This firm fixed price delivery order, which is not set-aside, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated as SPE2DX, valued at $999,999,999.00 and extending through December 2026. The product will be performed...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Concerta ER 36 mg tablets (100-count units) with a ceiling value of $5,573.88. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procedures. The contract will be performed in Conshohocken, Pennsylvania, with an ultimate completion date of July 22, 2025. This delivery order is issued as a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Concerta ER 54 mg tablets (100-count units) valued at $10,648.92 under a firm fixed price contract. This is a non-set-aside, competitively awarded delivery order with a completion date of August 6, 2025, and will be performed at the vendor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Concerta ER 54 mg tablets (100-count units) valued at $9,978.49. This non-set-aside, firm fixed-price contract is scheduled for completion by July 22, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,765.28 for 100 tablets of Concerta ER 18 mg, with an ultimate completion date of August 6, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $4,043.52 to AmerisourceBergen Drug Corp for the supply of Concerta ER 54 mg tablets (100 count) with a firm fixed price structure. The contract was competitively awarded without a set-aside designation and carries an ultimate completion date of August 11, 2025. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency (DLA) awarded a $3,724.82 delivery order to AmerisourceBergen Drug Corp for 100 tablets of Concerta ER 54 mg on July 18, 2025, with an ultimate completion date of July 21, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order represents a single delivery against AmerisourceBergen's larger Indefinite Delivery Contract...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC64UDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $15,944.96 to AmerisourceBergen Drug Corp for the supply of Concerta ER 36 mg tablets (100-count units) under a firm fixed price contract. The award, issued on August 4, 2025, with an ultimate completion date of August 5, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this contract at its corporate office location in the same city. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and runs through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, serving customers including the Defense Health Agency and U.S. Coast Guard. Concerta ER, a commonly prescribed medication for attention deficit hyperactivity disorder, represents part of the company's broader portfolio of neurological and specialty medications delivered through the DLA's pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.9k | 8/4/25 |